SEONGNAM, South Korea--(BUSINESS WIRE)--GI CELL, Inc. announced today that it has entered into a research license and option agreement with Optieum Biotechnologies, Inc. (Japan). Under the agreement, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results